logo
Select company
Select metric
-180.75%Return on Assets
VS
Market
3
Sector
8
Industry
11
History
12
$ 3.98Close
$ 3.57 - $ 19.8 52-Week Range
Ticker Information

Ticker

CLSD

Company Name

CLEARSIDE BIOMEDICAL INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

CLEARSIDE BIOMEDICAL INC - Return on Assets Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

CLSD - ROA Historical data
DateTotal AssetsNet Income Common StockReturn on Assets
6/30/2025$ 15.33M$ -27.71M-180.75%
3/31/2025$ 19.67M$ -30.81M-156.66%
12/31/2024$ 25.13M$ -34.35M-136.72%
9/30/2024$ 29.16M$ -31.88M-109.31%
6/30/2024$ 33.93M$ -33.46M-98.59%
3/31/2024$ 40.14M$ -34.97M-87.11%
12/31/2023$ 34.02M$ -32.48M-95.49%
9/30/2023$ 34.42M$ -37.32M-108.41%
6/30/2023$ 39.19M$ -35.88M-91.56%
3/31/2023$ 44.7M$ -34.58M-77.38%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • CLEARSIDE BIOMEDICAL INC's latest trailing twelve months (TTM) ROA stands at -81.55%.
  • Over the past 5 years, CLEARSIDE BIOMEDICAL INC's average ROA has been -82.46%.
  • The median ROA for CLEARSIDE BIOMEDICAL INC during this period was -89.33%
  • CLEARSIDE BIOMEDICAL INC reached its highest ROA over the past 5 years at 0.88%.
  • The lowest ROA recorded by CLEARSIDE BIOMEDICAL INC in the same timeframe -180.75%

CLEARSIDE BIOMEDICAL INC's ROA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

ROA Benchmarks
CompanyROA
IGC : IGC PHARMA INC -79.84%PLUR : PLURI INC -58.38%RANI : RANI THERAPEUTICS HOLDINGS INC -175.68%SONN : SONNET BIOTHERAPEUTICS HOLDINGS INC -659.56%LSTA : LISATA THERAPEUTICS INC -75.21%DTIL : PRECISION BIOSCIENCES INC -71.84%RLYB : RALLYBIO CORP -81.67%ICU : SEASTAR MEDICAL HOLDING CORP -175.01%ONCO : ONCONETIX INC -240.02%ADVM : ADVERUM BIOTECHNOLOGIES INC -191.18%

Definition of Return on Assets

[Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.
Net Inc. Cmn. / Assets
(=) ROA
ROA for CLEARSIDE BIOMEDICAL INC is calculated as follows: Net Inc. Cmn. [ $ -14.19M ] / Assets [ $ 17.41M ]
(=) ROA [ -81.55% ]

CLSD - Return on Assets, Last 5 years

-180.75%

Minimum

Jun 30, 2025

0.88%

Maximum

Dec 31, 2021

-82.46%

Average

-89.33%

Median

ROA Benchmark Analysis

The chart above depicts the distribution of ROA for companies in the Total Stock Market. The average ROA of the companies is 0.12% with a standard deviation of 10.61%.
The following table provides additional summary stats:
ROA in the Market:
filtered constituents3.44K
min-33.4%
max33.98%
average0.12%
median1.53%
std10.61%